PatientsLikeMe ™

ALS
Join Now (It's free!)

Already a member? Log in

Share your real-world treatment experience
with patients just like you.
Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


See also: Glucosamine, Glucosamine Chondroitin, Glucosamine Fish Oil, Glucosamine Plus

What is Glucosamine/Chondroitin/MSM? Glucosamine sulfate and chondroitin sulfate are components of normal cartilage. Methylsulfonylmethane (MSM) is a naturally occurring sulfur compound. The combination is said to nourish cartilage and connective tissue, improve wound healing and reduce pain from osteoarthritis. Read more...Click to read more below

See more information, including instructions, precautions, side effects, and interactions.


Reasons Taken

13 patients in the community are taking or have taken Glucosamine/Chondroitin/MSM.

Reason # Patients Percentage of patients
Other 6 46%
General health 3 23%
stiff joints 2 15%
Mobility 1 7%
Slow my ALS progress 1 7%

Dosages

Based on the patients currently taking Glucosamine/Chondroitin/MSM.

  0 mg day 500 mg day 750 mg day 900 mg day 1000 mg day 1200 mg day 1500 mg day
  2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2  

Duration

How long current patients have been taking Glucosamine/Chondroitin/MSM or how long patients were taking Glucosamine/Chondroitin/MSM before stopping.

Currently taking Glucosamine/Chondroitin/MSM

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
2
4
3

Stopped taking Glucosamine/Chondroitin/MSM

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
0
0
2
Why Patients Stopped Taking Glucosamine/Chondroitin/MSM (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 1 33% Did not seem to work: 33%
Expense 1 33% Expense: 33%
Personal research 1 33% Personal research: 33%
Not indicated 1 33% Not indicated: 33%


Back to top